<DOC>
	<DOCNO>NCT01814267</DOCNO>
	<brief_summary>The aim study ass cost-effectiveness telemedicine care chronic diabetic foot ulcer . Patients randomize 2 group : 1/conventional care group iterative visit diabetes specialist 2/innovative care ( telemedicine group ) . health insurance system perspective adopt .</brief_summary>
	<brief_title>Medico-economical Assessment Telemedicine During Chronic Diabetes-related Foot Wound Management</brief_title>
	<detailed_description />
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Patients type 1 2 diabetes , least 18 year old Patient diabetic foot wound : Acute chronic ( evolve least 30 day ) size ≤ 3 cm² Level I , II III , stage A B , exclude stage C D University Texas Wound Classification Systems Person affiliate French Health insurance equivalent Person sign freely consent form receive sufficient information Treatment compliance 6 month followup feasible Patient ischemic wound : AnkleBrachial Index ( ABI ) &lt; 0.9 Transcutaneous oxygen pressure ( TcpO2 ) &lt; 30 mmHg ( stage C D University Texas Wound Classification Systems ) Patient emergency hospitalization indication whatever reason . Person deprive liberty legal administrative decision , patient emergency people hospitalise without consent protect law . Pregnant breastfeed woman Patient currently participate another telemedicine research protocol ( : Study impact Telemedicine management patient type 1 diabetes ( TELEDIAB3 ) )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>innovative care</keyword>
	<keyword>telemedicine</keyword>
	<keyword>cost effectiveness</keyword>
	<keyword>diabetes</keyword>
</DOC>